HomeComparePJBF vs JNJ

PJBF vs JNJ: Dividend Comparison 2026

PJBF yields 0.28% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PJBF wins by $45.00 in total portfolio value
10 years
PJBF
PJBF
● Live price
0.28%
Share price
$53.67
Annual div
$0.15
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$28.90
Full PJBF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PJBF vs JNJ

📍 PJBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPJBFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PJBF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PJBF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PJBF
Annual income on $10K today (after 15% tax)
$24.11/yr
After 10yr DRIP, annual income (after tax)
$24.56/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $679.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PJBF + JNJ for your $10,000?

PJBF: 50%JNJ: 50%
100% JNJ50/50100% PJBF
Portfolio after 10yr
$20.0K
Annual income
$428.34/yr
Blended yield
2.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PJBF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PJBF buys
0
JNJ buys
0
No recent congressional trades found for PJBF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPJBFJNJ
Forward yield0.28%3.36%
Annual dividend / share$0.15$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.1K$20.0K
Annual income after 10y$28.90$827.78
Total dividends collected$287.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PJBF vs JNJ ($10,000, DRIP)

YearPJBF PortfolioPJBF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,728$28.37$10,676$355.77+$52.00PJBF
2$11,508$28.44$11,407$389.39+$101.00PJBF
3$12,342$28.51$12,198$426.53+$144.00PJBF
4$13,234$28.58$13,056$467.62+$178.00PJBF
5$14,189$28.64$13,987$513.12+$202.00PJBF
6$15,211$28.70$14,998$563.56+$213.00PJBF
7$16,305$28.75$16,098$619.52+$207.00PJBF
8$17,475$28.80$17,295$681.69+$180.00PJBF
9$18,727$28.85$18,599$750.82+$128.00PJBF
10$20,067$28.90$20,022$827.78+$45.00PJBF

PJBF vs JNJ: Complete Analysis 2026

PJBFStock

The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund invests at least 80% of its investable assets in equity and equity-related securities of companies that, at the time of investment, help address (or are anticipated to help address) social and environmental challenges as identified by one or more of the United Nations Sustainable Development Goals based on the subadviser's proprietary research and portfolio construction process. The Fund follows a growth investment style and will normally invest in a limited number of issuers. The Fund is an actively managed exchange-traded fund and therefore does not seek to replicate the performance of any specific index.

Full PJBF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PJBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PJBF vs SCHDPJBF vs JEPIPJBF vs OPJBF vs KOPJBF vs MAINPJBF vs ABBVPJBF vs MRKPJBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.